biohacking market share forecast
Is Growth Hacking Obsolete in Biohacking 2034?
Growth hacking is not obsolete in biohacking 2034; it now drives a 35% CAGR in neuroenhancement, adding $18 B to the market. Investors and founders are reshaping the playbook with AI-powered cohorts, micro-iterations, and real-time pivots, keeping acquisition costs lean while delivering health outcomes at speed. Medical Disclaimer: This article